Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;203(3):1465-1474.
doi: 10.1007/s12011-024-04274-6. Epub 2024 Jul 4.

Evaluation of Boric Acid Treatment on microRNA-127-5p and Metastasis Genes Orchestration of Breast Cancer Stem Cells

Affiliations

Evaluation of Boric Acid Treatment on microRNA-127-5p and Metastasis Genes Orchestration of Breast Cancer Stem Cells

Tuğba Semerci Sevimli et al. Biol Trace Elem Res. 2025 Mar.

Abstract

Coregulation of microRNAs (miRNAs) and cancer stem cells (CSCs) is very important in carcinogenesis. miR-127-5p is known to be downregulated in breast cancer. In this study, we aimed to investigate how boric acid (BA), known for its previously unstudied anti-cancer properties, would affect the expression of miR127-5p and genes responsible for breast cancer stem cells (BC-SCs) metastasis. BC-SCs were isolated from human breast cancer cells (MCF-7) by immunomagnetic cell separation and characterized with flow cytometry and sphere formation. The viability of BC-SCs and the determination of its IC50 value in response to boric acid (BA) were assessed via the MTT assay. Boric acid exhibited dose- and time-dependent inhibition of cell viability in cells. The IC50 doses of boric acid in MCF-7 cells and BC-SCs were 45.69 mM and 41.27 mM, respectively. The impact of BA on the expression of metastatic genes and miR127-5p was elucidated through RT-qPCR analysis. While the expression of the COL1A1 (p < 0.05) and VIM (p < 0.01) was downregulated, the expression of the miR-127-5p, ZEB1 (p < 0.01), CDH1 (p < 0.05), ITGB1 (p < 0.05), ITGA5 (p < 0.05), LAMA5 (p < 0.01), and SNAIL (p < 0.05), was up-regulated in dose-treated BC-SCs (p < 0.001) to the RT-qPCR results. Our findings suggest that boric acid could induce miR-127-5p expression. However, it cannot be said that it improves the metastasis properties of breast cancer stem cells.

Keywords: Boric acid; Breast cancer; Cancer stem cell; Metastasis; miR-127-5p.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical Approval: No ethical approval is required. Competing Interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Morphology of MCF-7 cells and BC-SCs as viewed under an inverted microscope. A MCF-7 cells. B Formation of cell spheres by BC-SCs in serum-free medium (scale bar = 200 µm)
Fig. 2
Fig. 2
BC-SCs exhibited an enhanced capacity for sphere formation (scale bar = 100 µM)
Fig. 3
Fig. 3
Flow cytometry analysis revealed the presence of BC-SCs. A CD326+ B CD117+/CD133+ C CD44+ D ABCG2 + cell populations on the surface of BC-SCs
Fig. 4
Fig. 4
Impact of boric acid on cancer stem cell proliferation. Cells were cultured in a medium with varying concentrations of boric acid (0–100 mM), and cell viability was assessed using the MTT assay after 48 h. Data are presented as the mean ± standard deviation from three independent experiments (mean ± SD, n = 3). Statistical significance was denoted as *p < 0.05, **p < 0.01, and ***p < 0.001, while “ns” indicates no significant difference
Fig. 5
Fig. 5
Expression profile of miR-127-5p and metastasis genes. In dose-treated BC-SCs, VIM and COL1A1 expression was significantly downregulated. Conversely, the expression levels of miR-127-5p, CDH1, ITGB1, ITGA5, ZEB1, SNAIL, and LAMA5 were notably up-regulated (mean ± SD, n = 3, *p < 0.05, **p < 0.01, and ***p < 0.001, with “ns” indicating no significant difference)

Similar articles

References

    1. Lu TX, Rothenberg ME (2018) MicroRNA. J Allergy Clin Immunol 141(4):1202–1207 - PMC - PubMed
    1. Hussen BM et al (2021) MicroRNA: a signature for cancer progression. Biomed Pharmacother 138:111528 - PubMed
    1. Reda El Sayed S, Cristante J, Guyon L, Denis J, Chabre O, Cherradi N (2021) MicroRNA therapeutics in cancer: current advances and challenges. Cancers (Basel) 13(11):2680. 10.3390/cancers13112680 - PMC - PubMed
    1. Umeh-Garcia M et al (2020) A novel bioengineered miR-127 prodrug suppresses the growth and metastatic potential of triple-negative breast cancer cells. Cancer Res 80(3):418–429 - PMC - PubMed
    1. Wang S et al (2014) Prognostic and biological significance of microRNA-127 expression in human breast cancer. Dis Markers 2014:401986 - PMC - PubMed

MeSH terms